Demographic characteristics of 58 cases Characteristic Value Age
- Slides: 7
Demographic characteristics of 58 cases Characteristic Value Age, years, median (range) 52 (16 -80) Age group, n(%) 10 -19 years 1 (1. 7%) 20 -29 years 3 (5. 1%) 30 -39 years 8 (13. 7%) 40 -49 years 14 (24. 1%) 50 -59 years 14 (24. 1%) 60 -69 years 8 (13. 7%) 70 -80 years 10 (17. 2%) Gender, n(%) Male 38 (65. 5%) Female 20 (34. 4%) Occupation, n(%) Healthcare worker 7 (12. 0%) Non healthcare worker 51 (87. 9%)
Symptoms of 45 cases Symptoms No (%) Fever 52 (89. 6%) Cough 20 (34. 4%) Sputum 13 (22. 4%) Myalgia 13 (22. 4%) Dyspnea 11 (18. 9%) Headache 8 (13. 9%) Diarrhea 6 (10. 3%) Throat pain 4 (6. 8%) Nausea 2 (3. 4%) Mental change 3 (3. 4%) Hemoptysis 1 (1. 7%) Andominal pain 1 (1. 7) Rhinorrhea 0 Vomitting 0 Asymptomatic 1 (1. 7%) Others (dizziness, chills) 4 (6. 8%)
Comorbidities of 45 cases Comorbidities Hypertension 10 (17. 2%) Diabetes mellitus 8 (13. 7%) Solid cancer 7 (12. 0%) Chronic lung disease 6 (10. 3%) Chronic liver disease 5 (8. 6%) Heart disease 5 (8. 6%) Current smoker 4 (6. 8%) Obesity 2 (3. 4%) CNS disease 2 (3. 4%) Hematologic malignancy 2 (3. 4%) Chronic kidney disease 0 Steroid use 0 Others (old tuberculosis, pneumonectomy, herpes zoster, drug intoxication, thyroidectomy, anemia, pancreatitis, chronic alcoholics, colectomy, liver abscess hemorrhoid, adjustment disorder, embolism) 13 (22. 4%) No comorbidities 21 (36. 2%)
Chest X ray & Vital signs of 45 cases Chest X ray finding at admission (n=58) No (%) Normal 27 (46. 5%) Unilateral infiltration 13 (22. 4%) Bilateral infiltration 16 (27. 5%) Not done 2 (3. 4%) Vital sign at admission (n=45) Systolic BP<90 mm. Hg 2 (3. 4%) RR>24/min 4 (6. 8%) BT>38°C 17 (29. 3%) BT<36°C 0
Laboratory findings of 45 cases Laboratory finding at admission WBC, /μL, median (range) (n=49) 4750 (1500 -17990) Hb, g/d. L, median (range) (n=49) 13. 4 (6. 6 -16. 5) Platelet, /μL, median (range) (n=49) 159000 (17000 -453000) BUN, mg/d. L, median (range) (n=48) 12 (4 -31. 9) Cr, mg/d. L, median (range) (n=48) 0. 81 (0. 3 -1. 21) Albumin, g/d. L, median (range) (n=48) 3. 6 (2. 1 -4. 9) AST, IU/L, median (range) (n=48) 42 (12 -2276) ALT, IU/L, median (range) (n=48) 27 (10 -1358) Pa. O 2, mm. Hg, median (range) (n=15) 74 (54. 6 -133) Laboratory abnormality, no of finding/no of tested patients (%) patients with abnormal Leukopenia (WBC<4000/μL) 20/49 (40. 8%) Leukocytosis (WBC>10000/μL) 1/49 (2%) Thrombocytopenia (Platelet<140000/μL) 13/49 (26. 5%) Cr elevation (Cr>1. 5 mg/d. L) 0/48 Hypoalbuminemia (albumin <3. 5 g/d. L) 20/48 (41. 6%) Hepatitis (AST>40 IU/L) 25/48 (52. 0%)
Treatment and outcomes of 42 cases Treatment No of treatment/no of subjects (%) ICU 9/54 (16. 6%) Ventilator 6/50 (12%) ECMO 1/50 (2%) Hemodialysis 2/49 (4. 0%) Interferon 23/52 (44. 2%) Ribavirin 25/52 (48. 0%) Lopinavir/ritonavir 13/52 (25%) Antibacterial treatment 29/52 (55. 7%) Death 2/58 (3. 4%) Afebrile state, no of afebrile/no of subjects(%) 3 days after admission 18/47 (38. 2%) 7 days after admission 13/24 (54. 1%) 14 days after admission 3/7 (42. 8%) Radiological improvement among patients with initial abnormal chest X ray(no of improved: no of worsened: no of no change) 3 days after admission 6: 8: 8 7 days after admission 5: 3: 2 14 days after admission 1: 0: 0
